VIRPAX PHARMACEUTICALS INC
VIRPAX PHARMACEUTICALS INC
Share · US9282511073 · VRPX (XNAS)
Overview Financial Indicators
0,27 USD
10,99 % 0,03 USD
NASDAQ (XNAS) · Current prices and charts at MoneyPeak
06.06.2025 16:12

Current Prices from VIRPAX PHARMACEUTICALS INC

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
VRPX
USD
06.06.2025 16:12
0,27 USD
0,24 USD
+10,99 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
10,99 % 8,59 % -8,07 % -94,47 % -97,33 % -98,52 % -99,98 %

Company Profile for VIRPAX PHARMACEUTICALS INC Share

Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system disorders. Its preclinical stage product candidates include Epoladerm, a topical nonsteroidal anti-inflammatory drug treatment for chronic osteoarthritis of the knee; Probudur, an injectable local anesthetic liposomal gel technology for postoperative pain management; and Envelta, a nanotechnology-based intranasal spray drug product candidate that enables the delivery of a metabolically labile peptide drug into the brain. The company's preclinical stage product candidates also comprise PES200, which enables the delivery of a metabolically labile peptide drug into the brain; AnQlar, an anti-viral barrier to prevent or reduce the risk or the intensity of viral infections in humans, including influenza and SARS-CoV-2; and VRP324, an investigational formulation to be delivered via the nasal route to enhance cannabidiol transport to the brain. Virpax Pharmaceuticals, Inc. was founded in 2016 and is headquartered in Berwyn, Pennsylvania.

Company Data

Name VIRPAX PHARMACEUTICALS INC
Company Virpax Pharmaceuticals, Inc.
Symbol VRPX
Website https://www.virpaxpharma.com
Primary Exchange XNAS NASDAQ
ISIN US9282511073
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. Jatinder Dhaliwal
Country United States of America
Currency USD
Employees 0,0 T
Address 1055 Westlakes Drive, 19312 Berwyn
IPO Date 2021-02-17

Stock Splits

Date Split
21.03.2025 1:25
01.03.2024 1:10

Ticker Symbols

Name Symbol
NASDAQ VRPX

More Shares

Investors who VIRPAX PHARMACEUTICALS INC hold also have the following shares in their portfolio:
ALBERTA 24/29
ALBERTA 24/29 Bond
LBBW         FZA NH 21/29
LBBW FZA NH 21/29 Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025